ArticleFrontiers in endocrinology2026
Spindle-to-oocyte light retardance ratio as a noninvasive biomarker for oocyte quality assessment: a prospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polarized light (PL) imaging provides a noninvasive strategy to assess oocyte quality and maturity. This prospective study aims to identify PL parameters in metaphase II (MII) oocytes that serve as adjunctive indicators for usable blastocyst formation. Methods: From August 2024 to August 2025, we studied 581 mature oocytes from women aged ≤ 38 years undergoing autologous Results: Through PL imaging, we identified the oocytes with superior developmental competence. Oocytes with a visible MII spindle achieved significantly higher developmental rates-notably for usable blastocyst development-than did those without an MII spindle (46.1% vs. 15.6%). MII oocytes with high spindle and ZP birefringence demonstrated the highest usable blastocyst rate (53.7%) and spindle-to-oocyte light retardance ratio (SOLRR; 0.011 ± 0.003). In multivariate analysis, SOLRR and anti-Müllerian hormone were significant positive and negative predictors of usable blastocyst formation (adjusted odds ratios = 1.148 and 0.939, respectively). SOLRR alone demonstrated moderate predictive power (area under the receiver operating characteristic curve = 0.63). Oocytes with high SOLRR (≥0.01127) consistently outperformed those with low SOLRR (<0.01127), achieving a higher usable blastocyst rate (61.8% vs. 38.0%). In TL analysis, the high SOLRR group demonstrated faster embryonic progression than the low SOLRR group did, indicated by faster blastocyst formation (108.2 vs. 111.2 h) and blastocoel expansion (8.7 vs. 10.2 h); this group also achieved a higher nonreverse cleavage rate (95.4% vs. 86.8%) and superior trophectoderm morphology (58.0% vs. 40.7%). Conclusions: PL imaging can be used to identify oocytes with superior developmental potential. SOLRR serves as an exploratory but quantifiably objective indicator of oocyte competence, independently predicting oocytes with relatively high usable blastocyst formation rates, rapid embryonic progression, and improved trophectoderm morphology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.